Radiation nanomedicines for treatment of GBM were synthesized by integrating the AE-emitter, 197Hg into AuNPs which were subsequently conjugated to panitumumab to target EGFR overexpressed on human GBM cells or remained non-targeted. The gene discussed is EGFR; the disease is glioblastoma.